clinicaltrialsarena8h
Intellia reports positive data from Phase II study of NTLA-2002 for HAE
Intellia has reported positive results from its ongoing Phase I/II trial of NTLA-2002, a CRISPR-based gene editing therapy ...
clinicaltrialsarena13h
Second Alzheimer’s drug rejected by NICE on the same day it is approved in the UK
NICE’s decisions for both drugs are not final and are pending more evidence. Credit: Art_Photo via Shutterstock. On 23 ...
clinicaltrialsarena14h
ImmunityBio commences CD19 t-haNK cell therapy trial for NHL
ImmunityBio has announced the commencement of a Phase I trial evaluating its CD19 (t-haNK) cell therapy for the treatment of ...
clinicaltrialsarena23h
Marinus’ clinical trial of ganaxolone fails to meet primary endpoint
The trial aimed to demonstrate a significant change in the 28-day frequency of TSC-associated seizures. Credit: Volha_R/Shutterstock. Marinus Pharmaceuticals has reported that the Phase III TrustTSC ...
clinicaltrialsarena23h
GeneDx reveals new findings from newborn genetic screening study
Using GeneDX’s technology, the GUARDIAN study screens newborns for 255 early-onset genetic conditions. Credit: Maliutina Anna via Shutterstock. GeneDx has unveiled new findings from the GUARDIAN study ...